Cambridge researchers are developing implants to help repair brain pathways damaged by Parkinson’s disease. As part of a £69 ...

Scientists from Rice University and their collaborators have unveiled a groundbreaking technique to combat cancer cells, ...

CIRM’s Education and Training programs are a vital link to tomorrow. The California Institute for Regenerative Medicine (CIRM) offers invaluable educational and training pathways in regenerative ...

Results from a new study published in Clinical and Translational Immunology found that dual-target antibody therapy can enhance cancer-fighting T cells more effectively than current single-target ...

I think the biggest tragedy in all of this is standing by on a billing code and refusing to be human and even reach out to ...

Although CAR T-cell therapies have been found effective against certain difficult-to-treat malignancies, they are not devoid of safety concerns.

Interrupting signals exchanged between tumors and the nervous system could become a critical pillar of cancer care ...

The FDA accepted Regeneron’s BLA resubmission for linvoseltamab in relapsed or refractory multiple myeloma, with a decision ...

Gut bacteria are to blame for the failure of immune checkpoint therapy for ovarian cancer, new research reveals.

By targeting surface markers on cancer cells, engineered synthetic receptors expressed on immune cells can be directed to ...

NSYNC’s Lance Bass shares his journey with type 1.5 diabetes, also known as latent autoimmune diabetes in adults (LADA). The ...

Organoids were cultured from healthy donor iPSC sources and differentiated using the human iPSC-derived Cerebral Organoid ...